Evidence map›Paper›PMID 35224624›Full record

ArticleThe Journal of antimicrobial chemotherapy2022

Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans.

Raquel Garcia-Fierro, Antoine Drapeau, Melody Dazas, Estelle Saras, Carla Rodrigues, Sylvain Brisse, Jean-Yves Madec, Marisa Haenni

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Carbapenem-ResistantMicroorganisms · 2026
    Review
  3. Evolution and Antimicrobial Resistance Profiles ofAntibiotics (Basel, Switzerland) · 2026
    Article
  4. Carbapenemase-Producing Enterobacterales in Pets: A New Threat From Veterinary Clinics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Microorganisms · 2026
    Review
  10. Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026
    Article
  11. One Health genomic surveillance ofFrontiers in microbiology · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Methicillin-resistant and methicillin-susceptibleOne health (Amsterdam, Netherlands) · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. First Detection of International High-RiskTransboundary and emerging diseases · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Raquel Garcia-FierroUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.ORCID 0000-0002-4612-4020
Antoine DrapeauUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Melody DazasUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Estelle SarasUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Carla RodriguesInstitut Pasteur, Université de Paris, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.ORCID 0000-0002-9608-2404
Sylvain BrisseInstitut Pasteur, Université de Paris, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France.ORCID 0000-0002-2516-2108
Jean-Yves MadecUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.
Marisa HaenniUnité Antibiorésistance et Virulence Bactériennes, Université Claude Bernard Lyon 1 - ANSES, Lyon, France.ORCID 0000-0003-1333-5603
Université Claude Bernard Lyon 1 · FRInstitut Pasteur · FR

Funding

ANSESEJPEuropean Union's Horizon 2020 773830MedVetKlebs
6 · The paper itself

Abstract

backgroundWHO considers ESBL- and carbapenemase-producing Klebsiella pneumoniae a major global concern. In animals, ESBL- and carbapenemase-producing K. pneumoniae of human-related ST11, ST15 and ST307 have been reported, but not in the context of large WGS-based One Health investigations.

objectivesTo perform comparative phylogenomics on a large collection of multidrug-resistant (MDR) K. pneumoniae recovered from diseased companion animals and humans.

methodsMDR K. pneumoniae (n = 105) recovered from companion animals in France during 2010-18 were phenotypically characterized. All isolates were whole-genome sequenced using the NovaSeq technology and phylogenomic analysis across animal and human K. pneumoniae was performed using appropriate pipelines.

resultsbla CTX-M-15, blaDHA-1 and blaOXA-48 were strongly associated with IncFIIk, IncR and IncL plasmids, respectively. When compared with human K. pneumoniae genomes, four groups of closely related French human and animal isolates belonging to ST11, ST15 and ST307 were detected, suggesting the circulation of clones between the human and animal sectors at country level. A large cluster of 31 ST11-KL105 animal isolates from France and Switzerland suggested it corresponds to a sub-lineage that is particularly well-adapted to the animal host.

conclusionsThis study demonstrates the spread of blaCTX-M-15-carrying ST15 and ST307, and blaDHA-1-carrying ST11 K. pneumoniae clones in animal populations. ST11 was the main vector of blaOXA-48/IncL, despite the absence of carbapenem use in French animals. Comparative phylogenomics suggests cross-transmission of K. pneumoniae sub-lineages more prone than others to colonize/infect the animal host. Our data also evidenced the emergence of convergent hypervirulent and MDR K. pneumoniae in animals.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeKlebsiella InfectionsAnimalsBacterial Proteinsbeta-LactamasesHumansKlebsiella pneumoniaePetsPhylogenyBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID35224624
PMCPMC9047677
OpenAlexW4213444549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.